1997
DOI: 10.1007/bf00879664
|View full text |Cite
|
Sign up to set email alerts
|

Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-l-carnitine induced changes in skeletal muscle metabolism

Abstract: Carnitine derivatives, such as propionyl-l-carnitine (PLC), have been shown to improve walking distance in patients with obstructive peripheral artery disease (PAOD). The aim of this study was to ascertain whether technetium-99m sestamibi leg scintigraphy may be a useful tool in the evaluation of changes in skeletal muscle metabolism induced by chronic therapy with PLC. Twenty patients with clinical and instrumental evidence of PAOD were randomly assigned to a 3-month period of therapy with either PLC or place… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
2

Year Published

2008
2008
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 17 publications
0
6
0
2
Order By: Relevance
“…There may be two aspects of the mechanism underlying the effects of PLC: metabolic effects in skeletal muscle and restoration of endothelial function traditionally attributed to the antioxidant properties of PLC. Although some trials found no changes in blood flow in patients treated with PLC, 87,88 others demonstrated an improvement in hemodynamic flow 78,89,90 . These contradictory findings might be explained by differences in study design, since trials that showed enhanced blood flow included higher doses of PLC.…”
Section: Clinical Evidence Of the Therapeutic Value Of Plcmentioning
confidence: 99%
“…There may be two aspects of the mechanism underlying the effects of PLC: metabolic effects in skeletal muscle and restoration of endothelial function traditionally attributed to the antioxidant properties of PLC. Although some trials found no changes in blood flow in patients treated with PLC, 87,88 others demonstrated an improvement in hemodynamic flow 78,89,90 . These contradictory findings might be explained by differences in study design, since trials that showed enhanced blood flow included higher doses of PLC.…”
Section: Clinical Evidence Of the Therapeutic Value Of Plcmentioning
confidence: 99%
“…It means that the effect of statins originates from various actions (inhibition of the expression of essential adhesion molecules in leukocyte/endothelial connection and control chemotactic proteins, for example) 14 . Importantly, mortality triggered by sepsis is intrinsically related to the inflammatory response and cytokine production [5][6][7][8][9][10][11][12][13][14][15][16][17] .…”
Section: Discussionmentioning
confidence: 99%
“…This marker has been used as scintigraphic agent of myocardial perfusion in the evaluation of coronary artery disease. Moreover, 99mTc-sestamibi has been used to assess the perfusion of skeletal muscle in individuals with peripheral arterial disease 9 . The capture and retention of this component appear to be associated with mitochondrial integrity and cell viability 9,10 . This project aimed at examining the effects conferred by simvastatin which are not related to their lipid-lowering action in an experimental model of abdominal sepsis in rats.…”
Section: Introductionmentioning
confidence: 99%
“…Contemporary nuclear medicine applies radiopharmaceuticals, methods and programs enabling to estimate even small changes in lower limb muscle perfusion indexes evaluating by perfusion scintigraphy (23,24). The introduction of Tc 99m MIBI complex enabled researchers to study perfusion of the muscles (25)(26)(27)(28).…”
Section: Discussionmentioning
confidence: 99%